Abstract:Abstract Introduction There is lack of clarity of sleep disordered breathing (SDB)--including the role of nocturnal hypoxia and confounding influence of obesity--on the clinical course of human coronavirus disease 2019 (COVID-19). We postulate that SDB portends increased risk of adverse COVID-19 clinical outcomes even after accounting for confounding factors. Methods A retrospective cohort analysis of COVID-19 and sleep laboratory observational registries March-November 2020 within the Cleveland Clinic health system was performed. Ordinal logistic regression assessed the association of SDB indices and World Health Organization (WHO)-7 COVID-19 clinical outcome (hospitalization, use of supplemental oxygen, non-invasive ventilation, mechanical ventilation/ECMO and death) in an unadjusted model and adjusted for age, sex, race, body mass index(BMI,kg/m2),diabetes mellitus, hypertension, coronary artery disease, heart failure, asthma, chronic obstructive pulmonary disease (COPD), cancer and smoking using SAS software. Results Of 19,449 (32%) patients positive for SARS-CoV-2,2,290 (6%) had an available sleep study. The analytic sample included 1788 of which 1,484(64%) had an apnea hypopnea index (AHI, 3–4% hypopnea oxygen desaturation)≥5. The median duration from sleep study to COVID test was 5.8 years (IQR:3.3–9.0). Age was 56.5±14.4 years,50.4% female,28% African American with BMI=35.9±8.9kg/m2. Nine percent of patients were hospitalized,10% with supplemental oxygen,6% used non-invasive ventilation,2% required ECMO or mechanical ventilation and 2% died. For every AHI increase of 5, the odds of a higher WHO-7 level increased 2% (OR=1.02,95%CI1.01-1.04,p=0.005),but the association was mitigated in the adjusted model (OR=1.00,95%CI:0.98,1.02,p=0.80). Per 5% increase in time spent with SaO2<90%, the odds of a higher WHO-7 level increased 10% (OR=1.10,95%CI1.06-1.13,p=<0.001) persisting in the adjusted model(OR=1.06,95%CI:1.02–1.10,p=0.002). For every decrease of 5% mean SaO2, the odds of a higher level WHO-7 increased 56% (OR=0.56,95%CI:0.46–0.67,p<0.001) persisting in the adjusted model(OR=0.72,95%CI:0.58–0.89,p=0.003). Conclusion Even after adjustment for obesity, underlying cardiopulmonary disease and smoking, sleep-related hypoxemia was a potential key pathophysiologic mechanism associated with increased morbidity and mortality in COVID-19. Elucidation of sleep-related hypoxemia as a risk stratification measure, particularly given the silent hypoxia inherent to early COVID-19, is critical for future investigation, as is the role of sleep-related hypoxia reversal as a target to improve COVID-19 outcomes. Support (if any) Cleveland Clinic Neurologic Institute Resource Development Award

Nocturnal oxygen resaturation parameters are associated with cardiorespiratory comorbidities

Sustained oximetric desaturation as a cardiac risk indicator remains correlated with nonspecific sleep apnea indices.

How Are Sleep Characteristics Related to Cardiovascular Health? Results From the Population-Based HypnoLaus study

Severe desaturations increase psychomotor vigilance task-based median reaction time and number of lapses in obstructive sleep apnoea patients

Prospective Study of Nocturnal Desaturation in Patients Receiving Home Oxygen Therapy

Beat-to-beat cardiac repolarization lability increases during hypoxemia and arousals in obstructive sleep apnea patients

Neurocognitive correlates of nocturnal oxygen desaturation in a memory clinic population

Hypoxaemic load in sleep apnoea is associated with acute changes in T-wave amplitude

The impact of study type and sleep measurement on oxygen desaturation index calculation

Nocturnal Oxygen Desaturation Index is Inversely Correlated with Airflow Limitation in Patients with Chronic Obstructive Pulmonary Disease

Nocturnal oxygen saturation is associated with all-cause mortality: a community-based study

Time Spent with Saturation below 80% versus 90% in Patients with Obstructive Sleep Apnoea

0856 Association of Naturally Occurring Mild Intermittent Hypoxemia and Health Outcomes in Sleep Apnea

Cerebral saturation is associated with physical activity and post-discharge mortality in heart failure patients

Validation of oxygen saturations measured in the community by emergency medical services as a marker of clinical deterioration in patients with confirmed COVID-19: a retrospective cohort study

714 Sleep Disordered Breathing Polysomnographic Measures and COVID-19 Risk of WHO-7 Clinical Outcomes in a Large Health Care System

Obstructive sleep apnea, nocturnal hypoxemia, and retinal microvasculature: The Atherosclerosis Risk in Communities Study

Obstructive sleep apnoea and lung function, and their association with nocturnal hypoxemia: results from the Swedish CArdioPulmonary bioimage Study (SCAPIS) - a cross-sectional study

Ambulatory Blood Pressure in Relation to Oxygen Desaturation Index As Simultaneously Assessed by Nighttime Finger Pulse Oximetry at Home

Daytime Risk Factors Of Nocturnal Hyoxemia In Copd Patients Unqualified For Long-Term Oxygen Therapy

Correlation between Heart Rate Variability and Disease Severity in Obstructive Sleep Apnea